Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Clin Lung Cancer. 2017 Jun 20;19(1):e19–e28. doi: 10.1016/j.cllc.2017.06.004

Table 1.

Patient Demographics and Clinical Characteristics

T790M Positive T790M Negative p value
Total number of patients 69 28
Age (mean ± standard deviation) 65.2 ± 11.3 70.3 ± 11.5 p = 0.052
Gender
Male 22 6 p = 0.30
Female 47 22
Ethnicity
Caucasian 13 11 p = 0.14
Black 1 0
Asian 22 4
Hispanic 5 2
Other 5 0
Unknown 23 11
Smoking Status
Current or Former Smoker 18 4 p = 0.21
Never Smoker 51 24
EGFR Mutation
Exon 19 Deletion 43 15 p = 0.57
L858R 20 10
Exon 19 Deletion and L858R 2 0
Unknown 4 3
Stage
IV at Diagnosis 58 25 p = 0.51
Recurrent 11 3
Tumor Histology
  Adenocarcinoma 67 26 p = 0.28
 Squamous Cell Carcinoma 0 1
 Adenosquamous Carcinoma 2 1
Data Analysis
By RECIST 51 25
By Medical chart 18 3
Treated with first-line TKI 66 28
Treated with TKI rechallenge 29 14
Treated with chemotherapy 42 18